Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Valion Bio (TIVC) Return on Sales (2021 - 2025)

Valion Bio has reported Return on Sales over the past 5 years, most recently at 0.17% for Q3 2025.

  • For Q3 2025, Return on Sales fell 6.0% year-over-year to 0.17%; the TTM value through Sep 2025 reached 0.15%, down 9.0%, while the annual FY2024 figure was 0.07%, 14.0% up from the prior year.
  • Return on Sales for Q3 2025 was 0.17% at Valion Bio, up from 0.22% in the prior quarter.
  • Over five years, Return on Sales peaked at 0.04% in Q1 2021 and troughed at 0.22% in Q2 2025.
  • A 5-year average of 0.09% and a median of 0.06% in 2021 define the central range for Return on Sales.
  • Biggest five-year swings in Return on Sales: increased 4bps in 2024 and later fell -17bps in 2025.
  • Year by year, Return on Sales stood at 0.06% in 2021, then grew by 6bps to 0.06% in 2022, then dropped by -14bps to 0.06% in 2023, then crashed by -30bps to 0.08% in 2024, then plummeted by -107bps to 0.17% in 2025.
  • Business Quant data shows Return on Sales for TIVC at 0.17% in Q3 2025, 0.22% in Q2 2025, and 0.22% in Q1 2025.